Literature DB >> 19478246

Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea.

Kesinee Chotivanich1, Jetsumon Sattabongkot, Yien Kyong Choi, Jae Sun Park, Juntima Sritabal, Chae Seung Lim, Rachanee Udomsangpetch, Nicholas J White, Won Ja Lee.   

Abstract

The antimalarial susceptibility of ring stage (> 80%) Plasmodium vivax from the Republic of Korea, where long incubation-period strains are prevalent, was evaluated using the schizont maturation inhibition technique. During 2005-2007, susceptibility to seven antimalarial drugs was evaluated with 24 fresh isolates. The geometric mean (95% confidence interval) 50% inhibition concentration (IC(50)) were quinine 60 (54-75) ng/mL, chloroquine 39 (22-282) ng/mL, piperaquine 27 (17-58) ng/mL, mefloquine 39 (35-67) ng/mL, pyrimethamine 138 (89-280) ng/mL, artesunate 0.6 (0.5-0.8) ng/mL, and primaquine 122 (98-232) ng/mL. Positive correlations were found between quinine and mefloquine (r = 0.6, P = 0.004), piperaquine and chloroquine (r = 0.6, P = 0.008), and piperaquine and primaquine IC(50) values (r = 0.5, P = 0.01). Compared with P. vivax in Thailand, P. vivax in the Republic of Korea was more sensitive to quinine and mefloquine, but equally sensitive to chloroquine and artesunate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478246      PMCID: PMC3444524     

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  26 in total

1.  Ex-vivo short-term culture and developmental assessment of Plasmodium vivax.

Authors:  K Chotivanich; K Silamut; R Udomsangpetch; K A Stepniewska; S Pukrittayakamee; S Looareesuwan; N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Nov-Dec       Impact factor: 2.184

2.  Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia.

Authors:  J K Baird; H Basri; M J Bangs; B Subianto; L C Patchen; S L Hoffman
Journal:  Am J Trop Med Hyg       Date:  1991-05       Impact factor: 2.345

Review 3.  Unstable vivax malaria in Korea.

Authors:  H I Ree
Journal:  Korean J Parasitol       Date:  2000-09       Impact factor: 1.341

4.  Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.

Authors:  Jutta Marfurt; Ivo Müeller; Albert Sie; Peter Maku; Mary Goroti; John C Reeder; Hans-Peter Beck; Blaise Genton
Journal:  Am J Trop Med Hyg       Date:  2007-11       Impact factor: 2.345

5.  A strain of Plasmodium vivax characterized by prolonged incubation: the effect of numbers of sporozoites on the length of the prepatent period.

Authors:  P G Shute; G Lupascu; P Branzei; M Maryon; P Constantinescu; L J Bruce-Chwatt; C C Draper; R Killick-Kendrick; P C Garnham
Journal:  Trans R Soc Trop Med Hyg       Date:  1976       Impact factor: 2.184

6.  In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand.

Authors:  Kesinee Chotivanich; Rachanee Udomsangpetch; Wirongrong Chierakul; Paul N Newton; Ronatrai Ruangveerayuth; Sasithon Pukrittayakamee; Sornchai Looareesuwan; Nicholas J White
Journal:  Am J Trop Med Hyg       Date:  2004-04       Impact factor: 2.345

7.  A strain of Plasmodium vivax characterized by prolonged incubation: morphological and biological characteristics.

Authors:  P C Garnham; R S Bray; L J Bruce-Chwatt; C C Draper; R Killick-Kendrick; P G Sergiev; N A Tiburskaja; P G Shute; M Maryon
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

8.  Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua.

Authors:  Iwa W Sumawinata; Budhi Leksana; Awalludin Sutamihardja; Budi Subianto; David J Fryauff; J Kevin Baird
Journal:  Am J Trop Med Hyg       Date:  2003-04       Impact factor: 2.345

9.  Chloroquine-resistant Plasmodium vivax in Papua New Guinea.

Authors:  G J Schuurkamp; P E Spicer; R K Kereu; P K Bulungol; K H Rieckmann
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Mar-Apr       Impact factor: 2.184

10.  Malaria during pregnancy in an area of unstable endemicity.

Authors:  F Nosten; F ter Kuile; L Maelankirri; B Decludt; N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Jul-Aug       Impact factor: 2.184

View more
  9 in total

1.  In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.

Authors:  R N Price; J Marfurt; F Chalfein; E Kenangalem; K A Piera; E Tjitra; N M Anstey; B Russell
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

2.  In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China.

Authors:  Feng Lu; Qi Gao; Kesinee Chotivanich; Hui Xia; Jun Cao; Rachanee Udomsangpetch; Liwang Cui; Jetsumon Sattabongkot
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

3.  In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.

Authors:  Diana Fernández; César Segura; Margarita Arboleda; Giovanny Garavito; Silvia Blair; Adriana Pabón
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

Review 4.  Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax.

Authors:  Ric N Price; Sarah Auburn; Jutta Marfurt; Qin Cheng
Journal:  Trends Parasitol       Date:  2012-10-05

5.  Icacina senegalensis (Icacinaceae), traditionally used for the treatment of malaria, inhibits in vitro Plasmodium falciparum growth without host cell toxicity.

Authors:  Serigne O Sarr; Sylvie Perrotey; Ibrahima Fall; Saïd Ennahar; Minjie Zhao; Yérim M Diop; Ermanno Candolfi; Eric Marchioni
Journal:  Malar J       Date:  2011-04-11       Impact factor: 2.979

6.  Diagnosis and Treatment of Plasmodium vivax Malaria.

Authors:  J Kevin Baird; Neena Valecha; Stephan Duparc; Nicholas J White; Ric N Price
Journal:  Am J Trop Med Hyg       Date:  2016-10-05       Impact factor: 2.345

7.  Molecular Surveillance and Ex Vivo Drug Susceptibilities of Plasmodium vivax Isolates From the China-Myanmar Border.

Authors:  Weilin Zeng; Hui Zhao; Wei Zhao; Qi Yang; Xinxin Li; Xiaosong Li; Mengxi Duan; Xun Wang; Cuiying Li; Zheng Xiang; Xi Chen; Liwang Cui; Zhaoqing Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-11-01       Impact factor: 5.293

8.  In vivo Susceptibility of Plasmodium vivax to Chloroquine in Southeastern Iran.

Authors:  A Heidari; H Keshavarz; S Shojaee; A Raeisi; S Dittrich
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

9.  Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes.

Authors:  Jiangyan Li; Jie Zhang; Qian Li; Yue Hu; Yonghua Ruan; Zhiyong Tao; Hui Xia; Jichen Qiao; Lingwen Meng; Weilin Zeng; Cuiying Li; Xi He; Luyi Zhao; Faiza A Siddiqui; Jun Miao; Zhaoqing Yang; Qiang Fang; Liwang Cui
Journal:  PLoS Negl Trop Dis       Date:  2020-06-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.